Porphobilinogen synthase: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 60: Line 60:


== References ==
== References ==
{{reflist}}
{{reflist|2}}


== External links ==
== External links ==

Revision as of 18:34, 18 November 2015

WikiDoc Resources for Porphobilinogen synthase

Articles

Most recent articles on Porphobilinogen synthase

Most cited articles on Porphobilinogen synthase

Review articles on Porphobilinogen synthase

Articles on Porphobilinogen synthase in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Porphobilinogen synthase

Images of Porphobilinogen synthase

Photos of Porphobilinogen synthase

Podcasts & MP3s on Porphobilinogen synthase

Videos on Porphobilinogen synthase

Evidence Based Medicine

Cochrane Collaboration on Porphobilinogen synthase

Bandolier on Porphobilinogen synthase

TRIP on Porphobilinogen synthase

Clinical Trials

Ongoing Trials on Porphobilinogen synthase at Clinical Trials.gov

Trial results on Porphobilinogen synthase

Clinical Trials on Porphobilinogen synthase at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Porphobilinogen synthase

NICE Guidance on Porphobilinogen synthase

NHS PRODIGY Guidance

FDA on Porphobilinogen synthase

CDC on Porphobilinogen synthase

Books

Books on Porphobilinogen synthase

News

Porphobilinogen synthase in the news

Be alerted to news on Porphobilinogen synthase

News trends on Porphobilinogen synthase

Commentary

Blogs on Porphobilinogen synthase

Definitions

Definitions of Porphobilinogen synthase

Patient Resources / Community

Patient resources on Porphobilinogen synthase

Discussion groups on Porphobilinogen synthase

Patient Handouts on Porphobilinogen synthase

Directions to Hospitals Treating Porphobilinogen synthase

Risk calculators and risk factors for Porphobilinogen synthase

Healthcare Provider Resources

Symptoms of Porphobilinogen synthase

Causes & Risk Factors for Porphobilinogen synthase

Diagnostic studies for Porphobilinogen synthase

Treatment of Porphobilinogen synthase

Continuing Medical Education (CME)

CME Programs on Porphobilinogen synthase

International

Porphobilinogen synthase en Espanol

Porphobilinogen synthase en Francais

Business

Porphobilinogen synthase in the Marketplace

Patents on Porphobilinogen synthase

Experimental / Informatics

List of terms related to Porphobilinogen synthase

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Porphobilinogen synthase (or ALA dehydratase, or aminolevulinate dehydratase) synthesizes porphobilinogen through the asymmetric condensation of two molecules of aminolevulinic acid. All natural tetrapyrroles, including hemes, chlorophylls and vitamin B12, share porphobilinogen as a common precursor.

It catalyzes the second step of the biosynthesis of porphyrin. The porphobilinogen synthase catalyzed reaction is the first common step in the biosynthesis of all biological tetrapyrroles.

Porphobilinogen synthase is the prototype morpheein.[1]

Structure

The structural basis for allosteric regulation of PBGS is modulation of a quaternary structure equilibrium between octamer and hexamer (via dimers), which is represented schematically as 6mer* ↔ 2mer* ↔ 2mer ↔ 8mer. The * represents a reorientation between two domains of each subunit that occurs in the dissociated state because it is sterically forbidden in the larger multimers.[1]

PBGS Quaternary Structure Equilibrium.
The PBGS quaternary structure equilibrium includes an inactive hexamer (PDB id 1PV8) that does not have subunit interactions necessary for an ordered active site lid. Dissociation to the pro-hexamer dimer can be followed by a conformational change that reorients the two αβ-barrel domains to form the pro-octamer dimer. Association of pro-octamer dimer to octamer (PDB id 1E51) includes formation of subunit interfaces that support order in the active site lid.

PBGS is encoded by a single gene and each PBGS multimer is composed of multiple copies of the same protein. Each PBGS subunit consists of a ~300 residue αβ-barrel domain, which houses the enzyme's active site in its center, and a >25 residue N-terminal arm domain. Allosteric regulation of PBGS can be described in terms of the orientation of the αβ-barrel domain with respect to the N-terminal arm domain.

Each N-terminal arm has up to two interactions with other subunits in a PBGS multimer. One of these interactions helps to stabilize a "closed" conformation of the active site lid. The other interaction restricts solvent access from the other end of the αβ-barrel.

In the inactive mulimeric state, the N-terminal arm domain is not involved in the lid-stabilizing interaction, and in the crystal structure of the inactive assembly, the active site lid is disordered.

Allosteric Regulators of PBGS

As a nearly universal enzyme with a highly conserved active site, PBGS would not be a prime target for the development of antimicrobials and/or herbicides. To the contrary, allosteric sites can be much more phylogenetically variable than active sites, thus presenting more drug development opportunities.[1]

Phylogenetic variation in PBGS allostery leads to the framing of discussion of PBGS allosteric regulation in terms of intrinsic and extrinsic factors.

Intrinsic allosteric regulators

Magnesium

The allosteric magnesium ion lies at the highly hydrated interface of two pro-octamer dimers. It appears to be easily dissociable, and it has been shown that hexamers accumulate when magnesium is removed in vitro.[2]

pH

Though it is not common to consider hydronium ions as allosteric regulators, in the case of PBGS, side chain protonation at locations other than the active site has been shown to affect the quaternary structure equilibrium, and thus to affect the rate of its catalyzed reaction as well.

Extrinsic allosteric regulators

Small molecule hexamer stabilization

Inspection of the PBGS 6mer* reveals a surface cavity that is not present in the 8mer. Small molecule binding to this phylogenetically variable cavity has been proposed to stabilize 6mer* of the targeted PBGS and consequently inhibit activity.

Such allosteric regulators are known as morphlocks because they lock PBGS in a specific morpheein form (6mer*).[3]

Deficiency

A deficiency of porphobilinogen synthase is usually acquired (rather than hereditary) and can be caused by heavy metal poisoning, especially lead poisoning, as the enzyme is very susceptible to inhibition by heavy metals.[4]

Hereditary insufficiency of porphobilinogen synthase is called porphobilinogen synthase (or ALA dehydratase) deficiency poprhyria. It is an extremely rare cause of porphyria,[5] with less than 10 cases ever reported.[6] All disease associated protein variants favor hexamer formation relative to the wild type human enzyme.[5]

Heme synthesis—note that some reactions occur in the cytoplasm and some in the mitochondrion (yellow)

Lead poisoning works on the cellular level by binding to this enzyme, rendering it useless.

PBGS as the prototype morpheein

The morpheein model of allostery exemplified by PBGS adds an additional layer of understanding to potential mechanisms for regulation of protein function and complements the increased focus that the protein science community is placing on protein structure dynamics.[1]

This model illustrates how the dynamics of phenomena such as alternate protein conformations, alternate oligomeric states, and transient protein-protein interactions can be harnessed for allosteric regulation of catalytic activity.

References

  1. 1.0 1.1 1.2 1.3 Jaffe EK, Lawrence SH (March 2012). "Allostery and the dynamic oligomerization of porphobilinogen synthase". Arch. Biochem. Biophys. 519 (2): 144–53. doi:10.1016/j.abb.2011.10.010. PMC 3291741. PMID 22037356.
  2. Breinig S, Kervinen J, Stith L, Wasson AS, Fairman R, Wlodawer A, Zdanov A, Jaffe EK (September 2003). "Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase". Nat. Struct. Biol. 10 (9): 757–63. doi:10.1038/nsb963. PMID 12897770.
  3. Lawrence SH, Jaffe EK (2008). "Expanding the Concepts in Protein Structure-Function Relationships and Enzyme Kinetics: Teaching using Morpheeins". Biochem Mol Biol Educ. 36 (4): 274–283. doi:10.1002/bmb.20211. PMC 2575429. PMID 19578473.
  4. ALA dehydratase reaction, from NetBiochem at the University of Utah. Last modified 1/5/95
  5. 5.0 5.1 Jaffe EK, Stith L (February 2007). "ALAD porphyria is a conformational disease". Am. J. Hum. Genet. 80 (2): 329–37. doi:10.1086/511444. PMC 1785348. PMID 17236137.
  6. Overview of the Porphyrias at The Porphyrias Consortium (a part of NIH Rare Diseases Clinical Research Network (RDCRN)) Retrieved June 2011

External links